Use only as directed. For information, see HIBICLENS® Drug Facts.



HIBICLENS® gently and effectively cleanses skin and superficial wounds. Gentle enough for patients with sensitive skin, HIBICLENS® can be used daily.


Easily incorporated into a patient’s cleansing routine and leaves a layer of CHG protection without sticky residue.


Daily bathing of ICU patients with 4% chlorhexidine gluconate has significantly reduced the infection rates of MRSA, VRE, and bacteremias.1


Can continue killing pathogens for up to 24 hours2 and repeated use results in a cumulative effect.3


For over 30 years, HIBICLENS® has demonstrated its efficacy and safety. Recent studies continue to reinforce its effectiveness in reducing facility infection rates and defending the spread of MRSA and other staph infections in facilities.

Intensive Cleaning Unleashed.

HIBICLENS® helps prevent skin infection thereby reducing the risk of cross-infection.
Protect your patients -- use HIBICLENS® as part of your infection prevention strategy.

In a study4 simulating surgical use, the immediate bactericidal effect of HIBICLENS® after a single six-minute scrub resulted in a 99.9% reduction in resident bacterial flora, with a reduction of 99.98% after the eleventh scrub. Reductions on surgically gloved hands were maintained over the six-hour test period. HIBICLENS® displays persistent antimicrobial action. In one study5, 93% of a radiolabeled formulation of HIBICLENS® remained present on uncovered skin after five hours.

> Rupp Clinical Summary

Effect of hospital-wide chlorhexidine gluconate patient bathing on healthcare – associated infections

> Rao Clinical Summary

A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections

> Climo Clinical Summary

The effect of daily bathing with chlorhexidine gluconate: results of a quasi-experimental multicenter trial

> Powers Clinical Summary

Chlorhexidine bathing and microbial contamination in patients’ bath basins

full clinical studies >